Could Your Testosterone Levels Reveal a Hidden Health Risk?

Low testosterone levels may be linked to increased cardiovascular risks, according to a study published in the journal Endocrine Reviews and cited by the French health outlet Pourquoi Docteur. The research suggests that men with testosterone concentrations below 300 ng/dL face a 25% higher risk of heart disease compared to those with normal levels, based on a meta-analysis of 14 longitudinal studies involving over 50,000 participants.

The study, led by Dr. Marie Lefevre of the Paris Medical Institute, analyzed data from European and North American cohorts between 2010 and 2023. Researchers found that testosterone deficiency was associated with elevated cholesterol, insulin resistance, and arterial stiffness—factors that contribute to atherosclerosis. “Testosterone plays a critical role in maintaining vascular health,” Lefevre stated in a press release. “Its decline may act as an early biomarker for underlying cardiovascular vulnerability.”

Public health officials in France have begun incorporating testosterone screening into routine male health checkups, following the study’s publication. The French National Institute of Health and Medical Research (INSERM) issued a guideline in May 2026 advising primary care physicians to monitor testosterone levels in men over 45, particularly those with obesity or type 2 diabetes. “This isn’t a call for widespread supplementation,” emphasized Dr. Antoine Dubois, an endocrinologist at Hôpital Saint-Antoine. “But it highlights the need for proactive monitoring and lifestyle interventions.”

Experts caution that the relationship between testosterone and heart disease remains complex. While the study identifies a correlation, causation has not been definitively proven. Dr. Elena Martinez, a cardiologist at the University of California, San Francisco, noted that “testosterone levels often reflect broader metabolic health. Lower levels may be a consequence rather than a cause of cardiovascular risk factors.” She added that randomized controlled trials on testosterone replacement therapy have shown mixed results, with some studies linking it to increased clotting risks.

The findings align with earlier research from the American Heart Association (AHA), which in 2024 acknowledged a “modest association” between hypogonadism and coronary artery disease. However, the AHA’s 2025 update emphasized that more research is needed to determine whether correcting low testosterone improves outcomes. “We’re still in the early stages of understanding this connection,” said Dr. Raj Patel, a member of the AHA’s clinical guidelines committee.

For patients, the study underscores the importance of holistic health management. The European Society of Cardiology recommends addressing modifiable risk factors such as physical inactivity, poor diet, and sleep disorders, which can independently lower testosterone. “Lifestyle changes like weight loss and regular exercise can naturally boost testosterone while reducing heart disease risk,” said Dr. Sophie Moreau, a preventive medicine specialist at the University of Lyon.

As the medical community continues to investigate this link, clinicians advise against self-diagnosis or unregulated hormone therapy. “Testosterone levels vary widely among individuals,” cautioned Dr. Lefevre. “Only a qualified physician can interpret results in the context of a patient’s overall health.” Patients are encouraged to consult healthcare providers for personalized assessments rather than relying on online tests or supplements.